Beckman Coulter, Inc.: FDA filings under this applicant name

FDA lists 280 510(k) clearances under 2 spellings of the applicant name “Beckman Coulter, Inc.” (first 1993, latest 2026), plus 5 PMA and 1 De Novo decisions, across 103 product codes in 5 review panels. Median 510(k) review time under this name: 74 days. Since 2017 the median was 135 days, against 135 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

Caduvo groups this applicant name under Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid), based on public ownership records.

510(k) clearances per year

YearClearancesMedian review days
20122188
20137373
20147149
20153133
20163164
20177157
20182271
2019894
2020690
20212215
20224118
202314238
20241990
202510256
2026790

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Beckman Coulter, Inc. took a median 135 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 135 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
GKZCounter, Differential Cell2828
LTTPanels, Test, Susceptibility, Antimicrobial1212
JPKMixture, Hematology Quality Control1010
MMIImmunoassay Method, Troponin Subunit1010
JJXSingle (Specified) Analyte Controls (Assayed And Unassayed)99
JITCalibrator, Secondary88
LGDEnzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii77
JISCalibrator, Primary66
JJYMulti-Analyte Controls, All Kinds (Assayed)66
CGNAcid, Folic, Radioimmunoassay55

Plus 93 more product codes.

Review panels

Most recent Beckman Coulter, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K262597Access BNP IINBC2026-10-2085
K261109Access MeMed BVQPS2026-10-19199
K262109Access NT-proBNPNBC2026-09-2190
K252169Access BNP IINBC2026-03-24257
K254059Access anti-HBc IgMSEI2026-03-1386
K253687Access anti-HBc TotalSEI2026-02-1990
K251995Access anti-HAV IgMLOL2026-01-27214
K250588Access Rubella IgGLFX2025-11-17263
K252580iQ200 SeriesLKM2025-09-1026
K243846Access anti-HAVLOL2025-09-09267

270 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
P230015PMAAccess HBsAg, Access HBsAg Confirmatory, Access HBsAg Calibrator, Access HBsAg QC2025-10-17
DEN160047De NovoFlow Cytometric Test System For Hematopoietic Neoplasms2017-06-29
P090026PMAACCESS HYBRITECH P2PSA ON THE ACCESS IMMUNOASSAY SYSTEMS2012-06-14
P980041PMAACCESS AFP IMMUNOASSAY SYSTEM1999-02-08
P970038PMATANDEM-R FREE PSA IMMUNORADIOMETRIC ASSAY/TANDEM-MP FREE PSA IMMUNOENZYMETRIC ASSAY1998-03-10

Recalls

648 product recalls in 421 recall events; 105 initiated in the last five years. Most recent: 2026-09-21.

4 product recalls in 2 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 3 initiated in the last five years. Most often: Beckman Coulter Biomedical GmbH (3), Assuramed (1).

These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Device clinical trials

An industry sponsor named Beckman Coulter, Inc. is the lead sponsor of 4 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:

Parent company SEC filings

DANAHER CORP /DE/ (DHR): EDGAR filings, CIK 313616. Caduvo groups Beckman Coulter, Inc. under Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid); the parent's SEC registrant is entered by hand for the group, not matched by name.

FDA spellings included

FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Beckman Coulter, Inc.?

FDA lists 280 510(k) clearances under 2 spellings of the applicant name “Beckman Coulter, Inc.” (first 1993, latest 2026), plus 5 PMA and 1 De Novo decisions, across 103 product codes in 5 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Beckman Coulter, Inc.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Beckman Coulter, Inc. is 74 days. Since 2017: 135 days, versus 135 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Beckman Coulter, Inc.?

The most frequent FDA product codes under this applicant name are GKZ (Counter, Differential Cell, 28); LTT (Panels, Test, Susceptibility, Antimicrobial, 12); JPK (Mixture, Hematology Quality Control, 10).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup